S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 22,100
+500 (2.31%)
Last updated: Sep 17, 2025, 12:39 PM KST
S.Biomedics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | -8,838 | -6,691 | -10,321 | -6,327 | -5,667 | -7,747 | Upgrade |
Depreciation & Amortization | 1,853 | 1,725 | 1,553 | 1,517 | 1,448 | 1,349 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | -5.49 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -132.9 | -25.23 | -51.81 | -6.77 | -0.24 | -89.31 | Upgrade |
Stock-Based Compensation | 191.29 | 55.38 | 86.21 | 148.08 | 217.39 | 326.65 | Upgrade |
Provision & Write-off of Bad Debts | 322.93 | 12.67 | 174.99 | -160.05 | -188.31 | 447.77 | Upgrade |
Other Operating Activities | 3,841 | 1,856 | 4,564 | 3,105 | 1,666 | -214.12 | Upgrade |
Change in Accounts Receivable | -995.65 | 201.51 | -771.8 | -697.48 | 440.6 | -417.1 | Upgrade |
Change in Inventory | 640.8 | 71.14 | -830.05 | -817.71 | -204.21 | -45.37 | Upgrade |
Change in Accounts Payable | -0.61 | -292.73 | 63.31 | 379.86 | -423.02 | -63.87 | Upgrade |
Change in Other Net Operating Assets | -873.16 | -413.31 | -610.69 | -347.05 | -576.36 | 1,016 | Upgrade |
Operating Cash Flow | -3,992 | -3,500 | -6,149 | -3,205 | -3,287 | -5,437 | Upgrade |
Capital Expenditures | -2,982 | -1,390 | -1,847 | -9,295 | -474.49 | -182.63 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 22.14 | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -324.4 | -324.4 | - | -149.39 | -15.8 | -6.81 | Upgrade |
Investment in Securities | -6,921 | -8,547 | -6,655 | 2,708 | -3,445 | 8,996 | Upgrade |
Other Investing Activities | -116.84 | -86 | -343.25 | -43.69 | -64.87 | -8.56 | Upgrade |
Investing Cash Flow | -10,344 | -10,348 | -8,824 | -6,871 | -3,990 | 8,788 | Upgrade |
Long-Term Debt Issued | - | 11,775 | - | 7,000 | 4,860 | 1,400 | Upgrade |
Total Debt Issued | 11,775 | 11,775 | - | 7,000 | 4,860 | 1,400 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -138.5 | Upgrade |
Long-Term Debt Repaid | - | -2,573 | -1,156 | -732.69 | -1,061 | -446.73 | Upgrade |
Total Debt Repaid | -2,738 | -2,573 | -1,156 | -732.69 | -1,061 | -585.23 | Upgrade |
Net Debt Issued (Repaid) | 9,037 | 9,202 | -1,156 | 6,267 | 3,799 | 814.93 | Upgrade |
Issuance of Common Stock | 7,845 | 7,574 | 14,282 | - | - | 52.5 | Upgrade |
Other Financing Activities | 223.51 | 133.5 | -808.56 | 852.9 | 362.18 | 144.46 | Upgrade |
Financing Cash Flow | 17,106 | 16,909 | 12,318 | 8,020 | 4,161 | 2,432 | Upgrade |
Foreign Exchange Rate Adjustments | 11.8 | 11.89 | -0.86 | -9.47 | 59.35 | -20.4 | Upgrade |
Net Cash Flow | 2,782 | 3,074 | -2,656 | -2,066 | -3,057 | 5,763 | Upgrade |
Free Cash Flow | -6,974 | -4,890 | -7,996 | -12,501 | -3,762 | -5,620 | Upgrade |
Free Cash Flow Margin | -40.79% | -35.61% | -61.00% | -103.20% | -42.42% | -105.65% | Upgrade |
Free Cash Flow Per Share | -595.26 | -425.15 | -731.44 | -1223.19 | -370.56 | -555.91 | Upgrade |
Cash Interest Paid | 383.52 | 426.59 | 487.05 | 156.16 | 158.4 | 184.78 | Upgrade |
Cash Income Tax Paid | 112.47 | 78 | 31.47 | 3.22 | -20.09 | -16.97 | Upgrade |
Levered Free Cash Flow | -8,397 | -4,647 | -8,051 | -9,322 | -3,057 | -3,832 | Upgrade |
Unlevered Free Cash Flow | -7,900 | -4,150 | -7,499 | -8,867 | -2,636 | -3,510 | Upgrade |
Change in Working Capital | -1,229 | -433.4 | -2,149 | -1,482 | -762.99 | 489.64 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.